Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00989638 · ClinicalTrials.gov registry record

A Multi Modality Surveillance Program for Women At High Risk for Breast Cancer

A clinical trial of Breast Cancer, sponsored by University of Chicago.

Active
Registry status
305
Enrollment target
1
Study location

NCT00989638: Active study of Breast Cancer, sponsored by University of Chicago.

NCT00989638 is a study of Breast Cancer that is active but no longer recruiting, run by University of Chicago. The registered enrollment target is 305 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00989638, a study of Breast Cancer, is active but no longer recruiting, sponsored by University of Chicago.

ACTIVE NOT RECRUITING
Registry status
305 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to develop a coordinated, standardized screening program for the early detection of breast cancer in high-risk women. This would include Breast Mammography and Magnetic Resonance Imaging (MRI) examination of your breasts. The University of Chicago Department of Radiology is performing research to develop better ways of imaging the breast. The investigators would like to be able to reliably identify abnormal tissue and determine whether abnormal areas contain cancer without surgical procedures (i.e., a biopsy which involves removing breast tissue with a needle or surgical instrument). Annual mammography has already been recommended for the patient based on family history or personal history of cancer. In young women, dense breasts sometimes make it difficult to find abnormal changes on breast cancer screening (mammograms). MRI, in combination with mammography, may increase the rate of detection of early cancers. In addition, MRI can provide better images of breast tissue. The investigators hope to prove that combining multiple screening measures including biomarkers improves the chances that, if you have a small cancer or pre-cancer, it will be found early. This study will also evaluate quality of life measures during breast cancer screening and compare breast MRI and mammogram in a high-risk population. The investigators will establish a database of clinical characteristics, blood biomarkers and interventions that will be saved for future analysis and aid in the development of more effective screening in high-risk women. This research will also help us develop tools for studies in the future.

Conditions Studied

Study Locations (1)

Illinois

  • The University of Chicago - Chicago

Trial Details

FieldValue
Enrollment Target 305 participants
Start Date 2004-06-23
Est. Completion 2027-02
University of Chicago

796 total trials

What the registry record for NCT00989638 still lists

NCT00989638 is an observational study that tracks outcomes without assigning an intervention. The registered 305 participants enrollment target is mid-sized for trials with a published cap, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (89% lower).

The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 0 interventions.

NCT00989638 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT00989638 about?

NCT00989638 is a clinical study titled "A Multi Modality Surveillance Program for Women At High Risk for Breast Cancer". The purpose of this study is to develop a coordinated, standardized screening program for the early detection of breast cancer in high-risk women. This would include Breast Mammography and Magnetic Resonance Imaging (MRI) examination of your breasts. The University of Chicago Department of Radiology...

What is the current status of trial NCT00989638?

This trial is currently active not recruiting. The enrollment target is 305 participants. The study started on 2004-06-23. Estimated completion is 2027-02.

What conditions does trial NCT00989638 study?

This clinical trial studies the following conditions: Breast Cancer.

Who is sponsoring clinical trial NCT00989638?

This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00989638 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00989638's enrollment target sits among peer trials

305 274th of 1224 higher than 951 of 1,224 other Breast Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04107181 · 305 participants · NA

    Pilot Study for Speculum Free Cervical Cancer Screening

  • NCT05399056 · 305 participants · NA

    Improving Participation in Pulmonary Rehabilitation Through Peer Support and Storytelling

  • NCT05078970 · 306 participants · NA

    Advancing Suicide Intervention Strategies for Teens During High Risk Periods

  • NCT05843695 · 306 participants · NA

    Enhancing Psychotherapy for Veterans and Service Members With PTSD and Anxiety

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT00989638, the US trial registry maintained by the National Library of Medicine. NCT00989638 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.